Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.
Date: 8/06/2018
Author: Minister Office
Source: MoPH
The Minister of Public Health Responds in a Press Conference to the False Accusations Regarding Drugs' Pricing in Lebanon
 
Deputy Prime Minister and Health Minister Ghassan Hasbani held a press conference on drugs and their pricing mechanism. “It seems that there is someone who is fabricating false facts regarding drugs’ prices by misrepresenting them and misleading citizens through the dissemination of exceptions and distortion of laws. We would like to inform the citizens of the following:
 
*Drugs’ pricing principles in Lebanon have been based for decades on a pricing structure after consulting the ministries of finance, Economy and Trade, Industry, the syndicate of pharmaceutical importers and owners of warehouses, the Syndicate of the Pharmaceutical Manufacturers after consulting the Council of State.
 
The number of drugs registered in Lebanon to date: 5733 drugs
The number of drugs listed by the Consumer protection association: 17 drugs
i.e. 0.29% of the number of drugs available in the Lebanese market, knowing that the table includes errors and is incorrect in general.
 
Minister Hasbani added: “these 17 drugs listed in the table are not available in the Lebanese market or their mentioned prices are incorrect. For example:
  • Daonil 5 mg is not available in the Lebanese market; its registration has been canceled
  • Betaserc 24mg is not marketed in Lebanon with this dose
  • Taxotere 80mg is said to cost 834 thousand LBP in the table, while it actually costs 749 thousand LBP
And most importantly, the price of Taxotere in the manufacturing country is 488 thousand LBP, which is wrong. Its sale price in the manufacturing country Germany is 783 euros, which is equal to 1.400.000 LBP, while it is sold in Lebanon at 749 thousand LBP, which is much cheaper than its price in its origin country.”
 
“As for the remaining drugs, they are locally manufactured and not imported as mentioned in the table, and their pricing was approved according to law No. 1/278 of 11/05/2013, knowing that the drugs locally manufactured do not exceed 7 to 8 % of that found in the Lebanese market.”
 
Minister Hasbani noted that generics of some of these drugs are available and manufactured in Lebanon at lower prices. According to the applicable laws, the drugs listed can be replaced by the generics and the patient can ask his doctor to replace a drug with its generic.
Sitemap
© Copyrights reserved to Ministry of Public Health 2019